News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) Gets Non-Approvable Letter From US FDA For Dronedarone


8/31/2006 1:38:57 PM

PARIS, Aug 31 (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research) said on Thursday that U.S health authorities had rejected its application for dronedarone, a heart arrythmia treatment branded as Multaq.

>>> Discuss This Story


Read at Sharewatch
Read at Reuters

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES